Abstract
Inflammatory bowel diseases are associated with complex shifts in microbiota composition. However, it remains unclear whether specific subsets of commensal bacteria induce inflammatory bowel diseases in genetically susceptible hosts. In this study, we found that deficiency of the E3 ligase Itch, which leads to spontaneous colitis and rectal prolapse, is associated with alteration of the gut microbiota. 16S rRNA sequencing showed expansion of colitogenic Bacteroides sp. in Itch−/− mice. Treatment with broad-spectrum antibiotics substantially reduced colonic inflammation in Itch−/− mice. Microbiota of Itch−/− mice failed to induce spontaneous colitis upon transfer to Itch+/+ mice but aggravated chemically induced colitis. Furthermore, we found that Bacteroides vulgatus, which is expanded in Itch−/− mice, was sufficient to induce colon inflammation in Itch−/− mice.
The gastrointestinal tract is colonized by an extraordinarily large number of commensal microbes, within which Bacteroidetes, Firmicutes, and Proteobacteria are the dominant phyla (1, 2). The coexistence of resident commensals and a single layer of epithelial cells play a beneficial role in regulating both energy harvesting from nutrients and immune system function (3). A disturbance of this balanced state (dysbiosis) directly or indirectly contributes to persistent intestinal inflammation that manifests as the two distinct clinical entities of inflammatory bowel disease (IBD), Crohn disease, and ulcerative colitis (4–6). Therefore, determining the factors that regulate these complex host-commensal relationships and promote the development of colitis is of great clinical and scientific interest.
Posttranslational modification mediated by ubiquitin conjugation plays a crucial regulatory role in inflammation (7). Ubiquitination involves a cascade of biochemical reactions through ubiquitin-activating (E1) enzymes, ubiquitin-conjugating (E2) enzymes, and ubiquitin ligase (E3) enzymes (7). The E3 ubiquitin ligases are critical components of this system because they recognize, bind to, and recruit specific target proteins for ubiquitination (7).
Itch is an E3 ubiquitin ligase that belongs to the HECT (homologous to the E6-AP C terminus) family. Itch contains a protein kinase C–related C2 domain, four WW domains (each of which contain two conserved tryptophan residues), and the HECT ligase domain (8). A truncated mutation of human Itch results in inflammatory disorders, including enteropathy (9). We have demonstrated recently that Itch deficiency in mice leads to spontaneous development of rectal prolapse because of severe colonic inflammation (10). In this study, we demonstrate that Itch plays a crucial role in regulation of gut microbiota and colonic inflammation.
Materials and Methods
Mice
C57BL/6J mice were originally obtained from Jackson Laboratory and bred in-house for more than 10 generations. These mice were then crossed with Itch−/− mice and the resulting heterozygous mice were used as breeders. The littermate Itch+/+ and Itch−/− mice from these breeders were used in this study. Itch−/− mice have been described previously (10); Itch−/−Rorc−/− double knockout (DKO) mice were generated by crossing Itch−/− with Rorctm1Litt/J mice (10). All mice were backcrossed at least 10 times with wild-type (WT) mice. All mice were fed irradiated food and maintained in autoclaved cages. Mice used in this study were age-matched, both females and males were used without observing differences between genders. In all experiments, up to five mice were housed per cage. Littermates were assigned to experimental groups according to genotype. All mice used in this study were bred and housed in individually ventilated cages in the same room of the specific pathogen-free facility with autoclaved food and bedding in the barrier facility at the Baylor Institute for Immunology Research and University of Texas Southwestern Medical Center. All experiments were performed in accordance with the guidelines of the Institutional Animal Care and Use Committee of Baylor Research Institute and University of Texas Southwestern Medical Center.
16S rRNA gene sequencing
16S rRNA gene sequencing was performed on fecal pellets from Itch+/+ and littermate Itch−/− collected at 8 wk. In brief, the 16S rRNA gene V4 V region PCR primers 515/806 (11) were used in a single-step 30-cycle PCR using the HotStarTaq Plus Master Mix Kit (Qiagen, Hilden, Germany) under the following conditions: 94°C for 3 min, followed by 28 cycles (five cycles used on PCR products) of 94°C for 30 s, 53°C for 40 s, and 72°C for 1 min, after which a final elongation step at 72°C for 5 min was performed. Sequencing was performed at MR DNA (Shallowater, TX) on an Ion Torrent Personal Genome Machine following the manufacturer’s guidelines. Sequence data were processed using a proprietary analysis pipeline (MR DNA). In summary, sequences were depleted of barcodes and primers and then sequences <150 bp were removed; sequences with ambiguous base calls and with homopolymer runs exceeding 6 bp were also removed. Sequences were denoised, operational taxonomic units (OTUs) were generated, and chimeras were removed. OTUs were defined by clustering at 3% divergence (97% similarity). Final OTUs were taxonomically classified using BLASTn against a curated database derived from GreenGenes, Ribosomal Database Project-II, and National Center of Biotechnology Information (12). The raw data for 16s rRNA gene sequencing have been deposited to the National Center for Biotechnology Information Sequence Read Archive database (Sequence Read Archive accession: PRJNA605559).
Antibiotic treatment and Bacteroides reconstitution
The gut microbiota of 8-wk-old C57BL/6 mice was depleted by feeding a mixture of antibiotics in drinking water ad libitum for 4 wk. In brief, mice were provided 1 g/l ampicillin, 500 mg/l vancomycin, 1 g/l neomycin sulfate, and 1 g/l metronidazole in drinking water, as previously described (13). Bacteroides strains Bacteroides uniformis (ATCC 8492), Bacteroides caccae (ATCC 43185), Parabacteroides goldsteinii (ATCC BAA-1180), Bacteroides ovatus (ATCC 8483), and Bacteroides vulgatus (ATTC 8482) were purchased from American Type Culture Collection (Manassas, VA). Bacteroides strains were cultured in BBL Chopped Meat Carbohydrate Broth, Pre-Reduced II (BD Biosciences, Sparks, MD). Antibiotic-pretreated Itch−/− mice were gavaged 1 × 108 CFU per mouse, and mice were sacrificed after 4 wk.
Fecal transplantation and bacterial culture administration
The gut microbiota of 8-wk-old Itch+/+ mice was first depleted using antibiotics in their drinking water for 4 wk. For fecal transplant, fecal pellets from untreated Itch−/− mice were resuspended in PBS (one fecal pellet per 1 ml of PBS). A total of 200 μl of the resuspended pool fecal material was given by gavage to mice over 3 consecutive d, starting 1 d after the antibiotic treatment was stopped and then every week for 3 wk (14). Itch+/+ mice were then sacrificed after 12 wk of fecal transplant. The Itch+/+ mice that received microbiota of Itch−/− mice were ~6-mo-old at the end of experiment.
RT-PCR analysis
Total RNA was prepared using RNeasy Mini Kit (Qiagen) followed by cDNA synthesis using the Verso cDNA Kit (Thermo Fisher Scientific, Richardson, TX). Quantitative RT-PCR was performed on a Master-cycler Realplex (Eppendorf, Hamburg, Germany). A Light Cycler 480 SYBR Green I Master Reaction Mix (Roche, Basel, Switzerland) was used in a 20-μl reaction volume. The expression of individual genes was normalized to the expression of actin. Cycling conditions were 95°C for 2 min, followed by 50 cycles of 95°C for 15 s, 55°C for 15 s, and 72°C for 20 s.
Fecal bacterial DNA extraction
Bacterial fecal DNA was extracted using a commercial kit (QIAamp DNA Stool Mini Kit; Qiagen, Valencia, CA) following the manufacturer’s recommendations. Extracted genomic DNA was used as a template for PCR amplification of different bacterial species.
Dextran sulfate sodium–induced colitis
Acute colitis was induced with 2.5% (w/v) dextran sulfate sodium (DSS) (molecular mass 36–50 kDa; MP Biologicals, Solon, OH) dissolved in sterile, distilled water ad libitum for 5 d followed by normal drinking water for 3 d. Fresh DSS solution was provided on day 3. Mice were sacrificed on day 8. Scoring for stool consistency and occult blood was done as previously described (15). Briefly, stool scores were determined as follows: 0 = well-formed pellets, 2 = semiformed stools, and 4 = liquid stool that adhered to the anus. Bleeding scores were determined as follows: 0 = no blood, 2 = visible blood traces in stool, and 4 = gross rectal bleeding. Stool consistency scores and bleeding scores were added and presented as clinical scores.
Histopathology
Colons from Itch+/+ and Itch−/− were fixed in formalin and embedded in paraffin, and tissue sections (5 μm) were stained with H&E and blindly scored. Histopathological evaluation of the entire section was performed by determining the crypt distortion, inflammation, presence of the immune cell infiltration in intestine mucosa, and infiltration degree of immune cell in submucosa. Histology scores were determined as follows: 0 = no architectural changes, 1 = inflammatory infiltrate, 2 = lamina propria neutrophils and eosinophils, 3 = neutrophils in epithelium, 4 = crypt destruction, and 5 = erosions or ulceration.
Statistical analysis
For data with normal distribution, one-way ANOVA was performed. Differences between two groups were evaluated using an unpaired Student t test. The data are presented as the mean ± SD, and differences were considered statistically significant at p ≤ 0.05. GraphPad Prism statistical software (version 5.0; GraphPad Software, La Jolla, CA) was used for analyses.
Results
Gut microbiota is altered in Itch−/− mice
We reported recently that Itch negatively regulates IL-17 expression in the colonic mucosa by targeting ROR-γt for ubiquitination. Itch−/− mice spontaneously develop rectal prolapse because of severe colonic inflammation (10). Because emerging evidence suggests an intimate link between dysbiotic gut microflora and IL-17 in colon inflammation (16–18), we analyzed the microbiota composition of fecal pellets by 16S rRNA sequencing of the V4 region. The microbial compositions of Itch+/+ and Itch−/− mice were assessed using UniFrac, a phylogeny-based measure of the degree of similarity between microbial communities. Pairwise distances were determined for all pairs of samples based on the taxonomic representation (unweighted). Principal coordinate analysis based on the UniFrac distances was used to visualize the differences among samples.
We found that the Itch−/− mice hosted a significantly distinct bacterial population compared with littermate Itch+/+ control mice (Fig. 1A, 1B). Shannon and OTU rarefaction curves reached stable values, showing that the depth of sequencing would include most species found in the samples (Supplemental Fig. 1A, 1B). Itch+/+ mice had much less α diversity than Itch−/− mice as measured by the Shannon index (Supplemental Fig. 1C). Taxon-based analysis revealed that Itch−/− mice showed increased Bacteroidetes, whereas Itch+/+ mice exhibited a higher Firmicutes-to-Bacteroidetes ratio (Fig. 1C, 1D). Taxonomic abundance was influenced in Itch−/− mice at multiple levels. Several species of the Bacteroidaceae, Prevotellaceae, Streptococcaceae, and Rikenellaceae families were increased in relative abundance in Itch−/− mice, whereas the percentage of Bifidobacteriaceae family members were reduced (Fig. 1E). B. uniformis, B. caccae, P. goldsteinii, B. ovatus, and B. vulgatus were increased in Itch−/− mice (Fig. 1F). Fecal DNA PCR was performed to confirm the presence of the above species (Supplemental Fig. 2A). An age dependent change in microbiota of WT and Itch−/− mice was performed by fecal DNA PCR. Itch−/− mice started to show microbiota change at an early age compared with WT mice (Supplemental Fig. 2B). These data suggest an alteration in the gut microbiota of Itch−/− mice.
FIGURE 1.

Itch−/− mice have altered gut microbiota. Results from 16S rRNA sequencing of fecal pellets from Itch+/+ and Itch−/− mice, showing (A) unweighted UniFrac distance principal coordinate analysis of the fecal microbiota from 8 Itch+/+ (green dots) and 8 Itch−/− (red dots), (B) relative abundance of phylum-classified fecal microbiota, (C) percentage of Bacteroidetes present in fecal microbiota from Itch+/+ and Itch−/− mice, (D) Bacteroidetes-to-Firmicutes ratio in fecal microbiota from Itch+/+ and Itch−/− mice, and (E) percentage change in family level in fecal microbiota from Itch+/+ and Itch−/− mice. (F) Percentage change in species level in fecal microbiota from Itch+/+ and Itch−/− mice. Data represent mean ± SD. **p ≤ 0.01.
Broad-spectrum antibiotic treatment alleviates spontaneous colonic inflammation in Itch−/− mice
To determine if the commensal microbes of Itch−/− mice trigger colonic inflammation, we tested whether broad-spectrum antibiotic treatment would limit the development of spontaneous colitis. For this, we depleted the microbiota of Itch−/− mice by 4 wk of oral administration of vancomycin, neomycin, metronidazole, and ampicillin (19). Mice were sacrificed 5 wk after antibiotic treatment. Histological examination of colon sections showed reduced colon inflammation in the Itch−/− mice treated with antibiotics compared with age-matched untreated Itch−/− mice (Fig. 2A).
FIGURE 2.

Antibiotic treatment reduces spontaneous colon inflammation in Itch−/− mice. (A) Representative images of H&E-stained colon sections of Itch−/− and Itch−/− treated with an antibiotic mixture are shown along with histology score. Images were taken at original magnification ×10. (B–D) RNA isolated from Itch+/+, Itch−/−, and Itch−/− mice after antibiotic treatment and assayed by RT-PCR showed significant differences between the Itch−/− and antibiotic-treated Itch−/− groups in expression of (B) IL-17A and IL-17F, (C) chemokines, and (D) MMPs. Data represent mean ± SD. **p ≤ 0.01.
Because we demonstrated that deficiency of Itch leads to elevated IL-17 expression in the colonic mucosa (10), we analyzed the level of IL-17 expression in antibiotic-treated mice by RT-PCR experiments. As expected, the levels of IL-17A and IL-17F were significantly reduced in the antibiotic-treated mice compared with control untreated mice (Fig. 2B).
Because IL-17 promotes the inflammatory response by inducing multiple cytokines, chemokines, and matrix metalloproteinases (MMPs) (20), we analyzed the expression of genes encoding IL-17–induced chemokines and MMPs. Our results showed that antibiotic treatment substantially reduced the expression of CXCL1, CCL2, CCL7, CCL20, MMP1, MMP2, MMP3, and MMP13 mRNA in Itch−/− colons (Fig. 2C, 2D). These results suggest that the commensal microbiota contribute to spontaneous colitis in Itch−/− mice.
Reconstitution of Itch−/− microbiota in Itch+/+ mice does not induce spontaneous colon inflammation
It has been shown that the microbiota of the mice that are genetically susceptible to develop colitis [e.g., T-bet−/− Rag2−/− (TRUC) mice (19), NLRP6−/− mice (21, 22), and NOD2−/− mice (23)] is transferable and induces severe colitis in WT mice upon cohousing. To test if the Itch−/− microbiota was transferable and induced colitis in WT mice, we treated WT mice with antibiotics to deplete the resident microbiota. Itch−/− fecal pellets were reconstituted in PBS, and 200 μl of the resuspended fecal sample was given by gavage to antibiotic-pretreated mice. This was repeated for 3 consecutive d, starting 1 d after the antibiotic treatment was stopped. Four weeks after the final gavage, fecal pellets were collected from the Itch−/− microbiota–recipient Itch+/+ mice. 16S rRNA sequencing showed that Itch+/+ mice were reconstituted with Itch−/− microbiota (Fig. 3A, 3B). To examine the dissimilarity between microbiota, we measured the Yue and Clayton (ΘYC) distances. There was increased variation in microbiota of WT (Itch+/+) with Itch−/− mice. Increased variation was also seen in microbiota of WT mice compared with WT mice gavaged with Itch−/− microbiota. There was much less variation between microbiota of Itch−/− mice and WT mice gavaged with Itch−/− microbiota as seen by ΘYC distances (Fig. 3C). Shannon and OTU rarefaction curves reached stable values, showing that the depth of sequencing included most species found in the samples (Supplemental Fig. 3A, 3B). Itch+/+ mice had less α diversity than Itch+/+ mice given Itch−/− microbiota as measured by Shannon index (Supplemental Fig. 3C).
FIGURE 3.

Reconstitution of Itch−/− microbiota in Itch+/+ mice does not induce spontaneous colon inflammation. Itch−/− microbiota was reconstituted in Itch+/+ mice, and 16S rRNA sequencing of fecal pellets was performed. The relative abundance of phylum-classified fecal microbiota differed between the groups, as shown in (A) histograms based on the proportion of OTUs per subject. (B) Differences were also seen in the unweighted UniFrac distance principal coordinate analysis of the fecal microbiota from 7 Itch+/+ (red dots), 7 Itch−/− (blue dots), and 7 Itch+/+ gavaged Itch−/− microbiota (green dots). (C) Changes in microbiota as measured by the ΘYC distance. (D) H&E staining of colon sections of Itch+/+ mice reconstituted with Itch−/− microbiota showed no morphological changes. Images were taken at original magnification ×10. (E) Histology score. (F and G) RNA isolated from Itch+/+ and Itch+/+ mice after reconstitution of microbiota showed no significant differences between the groups in expression of (F) IL-17A and IL-17F or (G) IL-6, TNF-α, and IL-1β by RT-PCR. Data represent mean ± SD. **p ≤ 0.01. ns, not significant.
To investigate if the Itch−/− microbiota induced colonic inflammation in Itch+/+ mice, we monitored body weight change and diarrhea in the recipient mice. Unexpectedly, no significant change in either body weight or diarrhea incidence was observed (data not shown). Similarly, histological examination showed neither signs of inflammatory infiltration nor any morphological changes (Fig. 3D, 3E). Additionally, the level of colitogenic cytokines such as TNF, IL-16, IL-1β, and IL-17 were similar to control mice (Fig. 3F, 3G). These data suggest that the colitis observed in Itch−/− mice is not transferable via its microbiota.
Reconstitution of Itch−/− microbiota in Itch+/+ mice aggravates DSS-induced colitis
Next, we tested if the Itch−/− microbiota affected chemically induced colitis in WT mice. We reconstituted antibiotic-pretreated WT mice with Itch−/− microbiota via oral gavage. These mice were then treated with 2.5% (w/v) DSS dissolved in sterile, distilled water ad libitum for 5 d followed by normal drinking water for 3 d. Body weight change, diarrhea score, and fecal occult blood (FOB) scores were monitored. As shown in Fig. 4A–C, Itch+/+ mice reconstituted with Itch−/− microbiota showed increased body weight loss, higher diarrhea score, and higher FOB score compared with Itch+/+ control mice. Itch−/− mice showed significantly higher scores than both Itch+/+ mice reconstituted with Itch−/− microbiota and Itch+/+ control mice. Histological examination of colon sections after DSS treatment also showed increased histology scores in Itch+/+ mice reconstituted with Itch−/− microbiota (Fig. 4D), suggesting severe colitis.
FIGURE 4.

Reconstitution of Itch−/− microbiota in Itch+/+ mice makes them more susceptible to DSS-induced colitis. Itch+/+ (n = 6), Itch−/− (n = 6), and Itch+/+ mice given Itch−/− microbiota (n = 6) were given 2.5% DSS solution for 5 d followed by 3 d of water. Mice were sacrificed on day 8. Significant differences between groups were seen in some daily recordings of (A) body weight, (B) diarrhea score, and (C) FOB, as well as in (D) histology scores. Data represent mean ± SD. *p ≤ 0.05, **p ≤ 0.01.
Microbiota of Itch−/−Rorc−/− DKO mice are similar to Itch−/− mice
We reported earlier that aged (6- to 8-mo-old) Itch−/− mice spontaneously develop rectal prolapse because of severe colonic inflammation. Mechanistically, we demonstrated that Itch targets ROR-γt for ubiquitination and the defect in this regulatory mechanism in Itch−/− mice resulted in elevated IL-17 levels in colonic mucosa. To investigate if the elevated IL-17 leads to altered microbiota in Itch−/− mice, we analyzed the microbiota composition of fecal pellets of Itch−/− Rorc−/− DKO mice. We found that the Itch−/− and Itch−/− Rorc −/− DKO mice hosted a significantly distinct bacterial population compared with littermate WT and Rorc−/− control mice (Fig. 5A, 5B). Taxon-based analysis showed that Itch−/−Rorc−/− DKO mice exhibited increased Bacteroidetes similar to that of Itch−/− mice (Fig. 5B, 5C). WT mice exhibited a higher Firmicutes-to-Bacteroidetes ratio similar to that of Rorc −/− mice (Fig. 5D).
FIGURE 5.

Itch−/− Rorc−/− DKO mice have altered gut microbiota. Results from 16S rRNA sequencing of fecal pellets from Itch+/+ and Itch−/− mice, showing (A) unweighted UniFrac distance principal coordinate analysis of the fecal microbiota from 6 Itch+/+ (red dots), 6 Itch−/− (green dots), 6 Rorc−/− (purple dots), and 6 Itch−/−Rorc−/− DKO mice (blue dots). (B) Relative abundance of phylum-classified fecal microbiota; (C) Percentage of Bacteroidetes present in fecal microbiota from Itch+/+, Itch−/−, Rorc−/−, and Itch−/−Rorc−/− DKO mice. (D) Bacteroidetes-to-Firmicutes ratio in fecal microbiota from Itch+/+ and Itch−/− mice. Data represent mean ± SD. **p ≤ 0.01.
B. vulgatus induces colon inflammation in Itch−/− mice
Because the Bacteroidaceae family was expanded in the microbiota of Itch−/− mice, we hypothesized that some member of this family triggers colitis in Itch−/− mice. To test this, we gavaged five species (B. uniformis, B. caccae, P. goldsteinii, B. ovatus, and B. vulgatus) in antibiotic-pretreated Itch−/− mice as described before (24). Only in mice inoculated with B. vulgatus did we observe body weight loss (Fig. 6A), decreased colon length (Fig. 6B), and, in histological examinations, increased crypt loss and infiltration of mononuclear cells (Fig. 6C, 6D). Mild inflammation was also observed in mice inoculated with P. goldsteinii (Fig. 6C, 6D).
FIGURE 6.

Bacteroides vulgatus induces colon inflammation in Itch−/− mice. Antibiotic-pretreated Itch−/− were gavaged with different Bacteroides strains (five mice per strain). Results show (A) percentage body weight change at the end of the experiment and (B) representative images of colons from Itch−/− and Itch−/− mice gavaged with B. vulgatus with weight/length ratio. (C) H&E staining of colon sections of Itch−/− mice gavaged with different Bacteroides strains. Images were taken at original magnification ×10. (D) Histology score of Itch−/− and Itch−/− mice gavaged with different Bacteroides strains. (E) IL-17A ELISA from the colon tissue explant of Itch−/− and Itch−/− mice gavaged with different Bacteroides strains, and (F) RT-PCR of IL-17A and IL-17F from colon tissue of Itch−/− and Itch−/− mice gavaged with different Bacteroides strains. **p ≤ 0.01.
Because we had shown that the colonic inflammation in Itch−/− mice is driven by IL-17, we measured the level of IL-17 using the colon explant cultures. Our results showed increased levels of IL-17A only in mice gavaged with B. vulgatus (Fig. 6E). Similar results were obtained in RT-PCR experiments using the mRNA isolated from colon tissue of Itch−/− with B. vulgatus (Fig. 6F). These results suggest that B. vulgatus is sufficient to induce colon inflammation in Itch−/− mice.
Discussion
Instability in the composition of the gut bacterial communities has been linked to IBDs (3). However, whether a specific commensal bacterial subset induces IBD and, if so, whether its proportions in the microbiota are altered during disease remains unclear. Also, the role of commensal bacteria in the context of specific host genotypes remains unclear. In this study, we demonstrate that Itch deficiency leads to expansion of colitogenic Bacteroides sp., which was associated with spontaneous colitis. Thus, our results demonstrate that Itch has an essential role in shaping a protective assembly of gut bacterial communities and suggest that manipulation of dysbiosis is a potential therapeutic approach in the treatment of IBDs.
Intestinal Bacteroides are among the most abundant members of the commensal microbiota (25). They benefit the host through breakdown of complex dietary carbohydrates and modulation of mucosal glycosylation, gene expression, angiogenesis, and immune maturation (26). However, in genetically susceptible hosts, some Bacteroides sp. induce colitis (24, 25). We found that inoculation of antibiotic-treated Itch−/− mice but not WT mice with B. vulgatus induced colonic inflammation. Our results are in line with previous reports that show that B. vulgatus induces colitis in IL-10−/−TGF-β−/− (DKO) mice (24) and in germ-free rats transgenically expressing HLA-B27 (27). It was shown that human enterotoxigenic B. fragilis induces colitis and promotes colon cancer growth in susceptible mice (28). However, we did not find B. fragilis colonization in Itch−/− mice. It needs to be determined whether B. fragilis could induce colitis in Itch−/− mice.
Genetic deletion of T-bet, Nod2, angiotensin-converting enzyme-2 (ACE2), and NLRP6 results in the emergence of transmissible, disease-predisposing commensals (19). However, the microbiota of Itch−/− mice failed to induce colitis in WT type mice but significantly enhanced chemically induced colitis. This genotype-dependent disparity in disease induction could be due to differences in host response.
Whether the altered microbiota is the cause or consequence of colonic inflammation in Itch−/− mice remains unclear. Although it can be argued that the observed changes in the gut microbiota are due to differences in the inflammatory state, the observation that a pure culture of B. vulgatus that was expanded in Itch−/− was sufficient to induce colitis suggests that the altered gut microbiota contributes to spontaneous colitis in Itch−/− mice. Further, Itch−/− RORC−/− mice exhibited microbial composition similar to Itch−/− mice suggesting that the alteration in the microbiota is independent of IL-17–driven inflammation. One possibility for alterations in the microbial community in Itch−/− mice could be due to changes in secretory mucins by the gut epithelial cells. In support of this possibility, we found low expression of MUC2 in the colonic mucosa of Itch−/− mice (Supplemental Fig. 4). Further, detailed analysis using epithelial cell–specific conditional knockout mice using gnotobiotic conditions would be necessary to fully elucidate the function of Itch in regulation of microbiota and colonic inflammation. Additionally, whether the alteration in the microbial composition observed in IBD patients is linked to defective Itch function in IBD patients (29) remains to be investigated. Nevertheless, this study highlights a novel, to our knowledge, function for the ubiquitin pathway in regulation of gut microbiota, which will open new avenues for exploration of this pathway. A clear understanding of the mechanism by which the gut mucosa discriminates between disease-predisposing microorganisms and mutualists could provide insights into disease onset in genetically predisposed individuals.
Supplementary Material
Acknowledgments
We thank Dr. Ezra Burstein for helpful discussions and Dr. Wayne Lancaster for critical reading of the manuscript.
This work was supported by grants from the National Institutes of Health (R01-DK115668-01), the Cancer Prevention Research Institute of Texas (RP160577), Baylor Charles A. Sammons Cancer Center and Baylor Scott and White Research Institute-Translational Genomics Research Institute collaborative grants (to K.V.), and Grant R01-DK117001 from the National Institutes of Health (to A.L.T.).
Abbreviations used in this article:
- DKO
double knockout
- DSS
dextran sulfate sodium
- FOB
fecal occult blood
- IBD
inflammatory bowel disease
- MMP
matrix metalloproteinase
- OTU
operational taxonomic unit
- WT
wild-type
- ΘYC
Yue and Clayton
Footnotes
The online version of this article contains supplemental material.
Disclosures
The authors have no financial conflicts of interest.
References
- 1.Ley RE, Hamady M, Lozupone C, Turnbaugh PJ, Ramey RR, Bircher JS, Schlegel ML, Tucker TA, Schrenzel MD, Knight R, and Gordon JI. 2008. Evolution of mammals and their gut microbes. Science 320: 1647–1651. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Tilg H, Adolph TE, Gerner RR, and Moschen AR. 2018. The intestinal microbiota in colorectal cancer. Cancer Cell 33: 954–964. [DOI] [PubMed] [Google Scholar]
- 3.Garrett WS, Gordon JI, and Glimcher LH. 2010. Homeostasis and inflammation in the intestine. Cell 140: 859–870. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Abraham C, and Cho JH. 2009. Inflammatory bowel disease. N. Engl. J. Med 361: 2066–2078. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Gevers D, Kugathasan S, Denson LA, Vázquez-Baeza Y, Van Treuren W, Ren B, Schwager E, Knights D, Song SJ, Yassour M, et al. 2014. The treatment-naive microbiome in new-onset Crohn’s disease. Cell Host Microbe 15: 382–392. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Knights D, Lassen KG, and Xavier RJ. 2013. Advances in inflammatory bowel disease pathogenesis: linking host genetics and the microbiome. Gut 62: 1505–1510. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Hershko A, and Ciechanover A. 1998. The ubiquitin system. Annu. Rev. Biochem 67: 425–479. [DOI] [PubMed] [Google Scholar]
- 8.Venuprasad K, Zeng M, Baughan SL, and Massoumi R. 2015. Multifaceted role of the ubiquitin ligase Itch in immune regulation. Immunol. Cell Biol 93: 452–460. [DOI] [PubMed] [Google Scholar]
- 9.Lohr NJ, Molleston JP, Strauss KA, Torres-Martinez W, Sherman EA, Squires RH, Rider NL, Chikwava KR, Cummings OW, Morton DH, and Puffenberger EG. 2010. Human ITCH E3 ubiquitin ligase deficiency causes syndromic multisystem autoimmune disease. Am. J. Hum. Genet 86: 447–453. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Kathania M, Khare P, Zeng M, Cantarel B, Zhang H, Ueno H, and Venuprasad K. 2016. Itch inhibits IL-17-mediated colon inflammation and tumorigenesis by ROR-γt ubiquitination. Nat. Immunol 17: 997–1004. [DOI] [PubMed] [Google Scholar]
- 11.Caporaso JG, Lauber CL, Walters WA, Berg-Lyons D, Lozupone CA, Turnbaugh PJ, Fierer N, and Knight R. 2011. Global patterns of 16S rRNA diversity at a depth of millions of sequences per sample. Proc. Natl. Acad. Sci. USA 108(Suppl. 1): 4516–4522. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.DeSantis TZ, Hugenholtz P, Larsen N, Rojas M, Brodie EL, Keller K, Huber T, Dalevi D, Hu P, and Andersen GL. 2006. Greengenes, a chimera-checked 16S rRNA gene database and workbench compatible with ARB. Appl. Environ. Microbiol 72: 5069–5072. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Rakoff-Nahoum S, Paglino J, Eslami-Varzaneh F, Edberg S, and Medzhitov R. 2004. Recognition of commensal microflora by toll-like receptors is required for intestinal homeostasis. Cell 118: 229–241. [DOI] [PubMed] [Google Scholar]
- 14.Ubeda C, Bucci V, Caballero S, Djukovic A, Toussaint NC, Equinda M, Lipuma L, Ling L, Gobourne A, No D, et al. 2013. Intestinal microbiota containing Barnesiella species cures vancomycin-resistant Enterococcus faecium colonization. Infect. Immun 81: 965–973. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Zaki MH, Vogel P, Malireddi RK, Body-Malapel M, Anand PK, Bertin J, Green DR, Lamkanfi M, and Kanneganti TD. 2011. The NOD-like receptor NLRP12 attenuates colon inflammation and tumorigenesis. Cancer Cell 20: 649–660. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Arthur JC, and Jobin C. 2011. The struggle within: microbial influences on colorectal cancer. Inflamm. Bowel Dis 17: 396–409. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Elinav E, Nowarski R, Thaiss CA, Hu B, Jin C, and Flavell RA. 2013. Inflammation-induced cancer: crosstalk between tumours, immune cells and microorganisms. Nat. Rev. Cancer 13: 759–771. [DOI] [PubMed] [Google Scholar]
- 18.Gagliani N, Hu B, Huber S, Elinav E, and Flavell RA. 2014. The fire within: microbes inflame tumors. Cell 157: 776–783. [DOI] [PubMed] [Google Scholar]
- 19.Garrett WS, Lord GM, Punit S, Lugo-Villarino G, Mazmanian SK, Ito S, Glickman JN, and Glimcher LH. 2007. Communicable ulcerative colitis induced by T-bet deficiency in the innate immune system. Cell 131: 33–45. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Dong C 2008. TH17 cells in development: an updated view of their molecular identity and genetic programming. Nat. Rev. Immunol 8: 337–348. [DOI] [PubMed] [Google Scholar]
- 21.Elinav E, Strowig T, Kau AL, Henao-Mejia J, Thaiss CA, Booth CJ, Peaper DR, Bertin J, Eisenbarth SC, Gordon JI, and Flavell RA. 2011. NLRP6 inflammasome regulates colonic microbial ecology and risk for colitis. Cell 145: 745–757. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Hu B, Elinav E, Huber S, Strowig T, Hao L, Hafemann A, Jin C, Wunderlich C, Wunderlich T, Eisenbarth SC, and Flavell RA. 2013. Microbiota-induced activation of epithelial IL-6 signaling links inflammasome-driven inflammation with transmissible cancer. [Published erratum appears in 2013 Proc. Natl. Acad. Sci. USA 110: 12852.] Proc. Natl. Acad. Sci. USA 110: 9862–9867. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Couturier-Maillard A, Secher T, Rehman A, Normand S, De Arcangelis A, Haesler R, Huot L, Grandjean T, Bressenot A, Delanoye-Crespin A, et al. 2013. NOD2-mediated dysbiosis predisposes mice to transmissible colitis and colorectal cancer. J. Clin. Invest 123: 700–711. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Bloom SM, Bijanki VN, Nava GM, Sun L, Malvin NP, Donermeyer DL, Dunne WM Jr., Allen PM, and Stappenbeck TS. 2011. Commensal Bacteroides species induce colitis in host-genotype-specific fashion in a mouse model of inflammatory bowel disease. Cell Host Microbe 9: 390–403. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Wexler AG, and Goodman AL. 2017. An insider’s perspective: Bacteroides as a window into the microbiome. Nat. Microbiol 2: 17026. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Kau AL, Ahern PP, Griffin NW, Goodman AL, and Gordon JI. 2011. Human nutrition, the gut microbiome and the immune system. Nature 474: 327–336. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Brakenhoff LK, van der Heijde DM, Hommes DW, Huizinga TW, and Fidder HH. 2010. The joint-gut axis in inflammatory bowel diseases. J. Crohn’s Colitis 4: 257–268. [DOI] [PubMed] [Google Scholar]
- 28.Wu S, Rhee KJ, Albesiano E, Rabizadeh S, Wu X, Yen HR, Huso DL, Brancati FL, Wick E, McAllister F, et al. 2009. A human colonic commensal promotes colon tumorigenesis via activation of T helper type 17 T cell responses. Nat. Med 15: 1016–1022. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Paul J, Singh AK, Kathania M, Elviche TL, Zeng M, Basrur V, Theiss AL, and Venuprasad K. 2018. IL-17-driven intestinal fibrosis is inhibited by Itch-mediated ubiquitination of HIC-5. Mucosal Immunol. 11: 427–436. [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
